Hurler syndrome overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 6: Line 6:


Hurler syndrome, also known as [[mucopolysaccharidosis]] type I (MPS I), Hurler's disease and gargoylism<ref>Gargoylism. gpnotebook.co.uk. URL: [http://www.gpnotebook.co.uk/cache/1644560391.htm http://www.gpnotebook.co.uk/cache/1644560391.htm]. Accessed on: April 29, 2007.</ref>, is a [[genetic disorder]] that results in the deficiency of [[alpha-L iduronidase]], which is an [[enzyme]] that breaks down [[mucopolysaccharides]].  Without this enzyme, the buildup of [[heparan sulfate]] and [[dermatan sulfate]] occurs in the body (the [[heart]], [[liver]], [[brain]] etc.). [[Symptom]]s appear during childhood and early death can occur due to [[organ (anatomy)|organ]] damage.
Hurler syndrome, also known as [[mucopolysaccharidosis]] type I (MPS I), Hurler's disease and gargoylism<ref>Gargoylism. gpnotebook.co.uk. URL: [http://www.gpnotebook.co.uk/cache/1644560391.htm http://www.gpnotebook.co.uk/cache/1644560391.htm]. Accessed on: April 29, 2007.</ref>, is a [[genetic disorder]] that results in the deficiency of [[alpha-L iduronidase]], which is an [[enzyme]] that breaks down [[mucopolysaccharides]].  Without this enzyme, the buildup of [[heparan sulfate]] and [[dermatan sulfate]] occurs in the body (the [[heart]], [[liver]], [[brain]] etc.). [[Symptom]]s appear during childhood and early death can occur due to [[organ (anatomy)|organ]] damage.
==Classification==
MPS I is divided into three subtypes based on severity of symptoms. All three types result from an absence of, or insufficient levels of, the enzyme alpha-L-iduronidase.  MPS I H or Hurler syndrome is the most severe of the MPS I subtypes. The other two types are MPS I S or [[Scheie syndrome]] and MPS I H-S or [[Hurler-Scheie syndrome]].


==References==
==References==

Revision as of 02:46, 26 February 2013

Hurler Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hurler Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hurler syndrome overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hurler syndrome overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hurler syndrome overview

CDC on Hurler syndrome overview

Hurler syndrome overview in the news

Blogs on Hurler syndrome overview

Directions to Hospitals Treating Hurler syndrome

Risk calculators and risk factors for Hurler syndrome overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hurler syndrome, also known as mucopolysaccharidosis type I (MPS I), Hurler's disease and gargoylism[1], is a genetic disorder that results in the deficiency of alpha-L iduronidase, which is an enzyme that breaks down mucopolysaccharides. Without this enzyme, the buildup of heparan sulfate and dermatan sulfate occurs in the body (the heart, liver, brain etc.). Symptoms appear during childhood and early death can occur due to organ damage.

Classification

MPS I is divided into three subtypes based on severity of symptoms. All three types result from an absence of, or insufficient levels of, the enzyme alpha-L-iduronidase. MPS I H or Hurler syndrome is the most severe of the MPS I subtypes. The other two types are MPS I S or Scheie syndrome and MPS I H-S or Hurler-Scheie syndrome.

References

  1. Gargoylism. gpnotebook.co.uk. URL: http://www.gpnotebook.co.uk/cache/1644560391.htm. Accessed on: April 29, 2007.